Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases

J Allergy Clin Immunol. 2017 Sep;140(3):685-687. doi: 10.1016/j.jaci.2017.04.029. Epub 2017 May 12.
No abstract available

Keywords: Drug development; biomarker; clinical trials; pharmacodynamics; trial design.

Publication types

  • Editorial

MeSH terms

  • Clinical Trials, Phase II as Topic*
  • Clinical Trials, Phase III as Topic*
  • Drug Development*
  • Humans
  • Immune System Diseases / drug therapy*
  • Research Design